SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-21-006265
Filing Date
2021-03-17
Accepted
2021-03-17 16:31:42
Documents
1
Period of Report
2021-03-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1567
  Complete submission text file 0001493152-21-006265.txt   2915
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208 (847) 787-7361
Eton Pharmaceuticals, Inc. (Issuer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5410 TENNESSEE AVE NASHVILLE TN 37209
Business Address
Adams Jennifer McKie (Reporting) CIK: 0001851440 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38738 | Film No.: 21750980